Your browser doesn't support javascript.
loading
Design of a cluster-randomized trial of the effectiveness and cost-effectiveness of metformin on prevention of type 2 diabetes among prediabetic Mexican adults (the PRuDENTE initiative of Mexico City).
Rodríguez, Luis A; Barquera, Simón; Aguilar-Salinas, Carlos A; Sepúlveda-Amor, Jaime; Sánchez-Romero, Luz María; Denova-Gutiérrez, Edgar; Balderas, Nydia; Moreno-Loaeza, Lizbeth; Handley, Margaret A; Basu, Sanjay; López-Arellano, Oliva; Gallardo-Hernández, Alberto; Schillinger, Dean.
Afiliación
  • Rodríguez LA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA. Electronic address: Luis.Rodriguez@ucsf.edu.
  • Barquera S; Nutrition and Health Research Center, National Institute of Public Health, Cuernavaca, Mexico.
  • Aguilar-Salinas CA; Division of Nutrition, Salvador Zubiran National Institute of Medical Sciences and Nutrition, Mexico City, Mexico.
  • Sepúlveda-Amor J; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA.
  • Sánchez-Romero LM; Nutrition and Health Research Center, National Institute of Public Health, Cuernavaca, Mexico.
  • Denova-Gutiérrez E; Nutrition and Health Research Center, National Institute of Public Health, Cuernavaca, Mexico.
  • Balderas N; Nutrition and Health Research Center, National Institute of Public Health, Cuernavaca, Mexico.
  • Moreno-Loaeza L; Research Unit on Metabolic Diseases, Salvador Zubiran National Institute of Medical Sciences and Nutrition, Mexico City, Mexico; Medical, Dental and Health Sciences, National Autonomous University of Mexico, Mexico City, Mexico.
  • Handley MA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Division of General Internal Medicine at San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA; UCSF Center for Vulnerable Populations, San Franc
  • Basu S; Department of Medicine, Stanford University, Palo Alto, CA, USA.
  • López-Arellano O; Ministry of Health, Mexico City, Mexico.
  • Gallardo-Hernández A; Ministry of Health, Mexico City, Mexico.
  • Schillinger D; Division of General Internal Medicine at San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA; UCSF Center for Vulnerable Populations, San Francisco General Hospital, San Francisco, CA, USA.
Contemp Clin Trials ; 95: 106067, 2020 08.
Article en En | MEDLINE | ID: mdl-32580032
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estado Prediabético / Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Mexico Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estado Prediabético / Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Mexico Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos